China Valves Technology, Inc. (CVVT) (”China Valves” or the “Company”), a leading metal valve manufacturer with operations in the People’s Republic of China (”China” or the “PRC”), today announced that the Company recently formally obtained a Qualified Supplier certificate from China Nuclear Power Engineering Corporation, Ltd. (”CNPEC”).

The certificate authorizes the Company to provide valves for conventional islands of nuclear power plants commissioned by CNPEC, as defined by the Company’s Special Equipment Manufacturing License issued by China’s State Quality Supervision & Inspection Bureau. In addition, the Company is also qualified to supply valves for Balance of Plant (BOP), the supporting system in a nuclear power plant. Only a few out of several thousands of valve manufacturers have obtained this certification from CNPEC. In order to qualify as a supplier, manufacturers must meet a range of predefined standards, such as having the ability to produce valves for power plants with a generation capacity of at least 300MW.

The Company estimates that approximately 45% of all valves in a typical nuclear power plant are used in the conventional island, while 11% are used in the BOP.

State-owned CNPEC, China’s largest company engaged in nuclear power research, development and operation, undertakes and has completed the most nuclear power engineering projects in China. Additionally, CNPEC has generated more than 300 nuclear power related industry standards and has a prominent role in the development and implementation of a plan for the nuclear power industry under China’s Eleventh Five-Year Plan.

“This certificate is an indication of confidence in our ability to deliver high-quality valves for demanding applications in the emerging nuclear power industry,” said Mr. Siping Fang, Chairman and Chief Executive Officer of China Valves. “China is aiming to become self-sufficient in nuclear power development, and is therefore increasingly relying on high-quality domestic suppliers. China Valves hopes to capitalize on this growing demand by actively developing our product offerings and improving quality.”

China Valves is already certified to supply valves used in conventional islands for China’s second largest nuclear power development company, Guangdong Nuclear Power Group (”GNPG”). It has yet to obtain the license to manufacture valves used in the core island of nuclear power plants.

About China Valves Technology, Inc.

China Valves Technology, Inc. through its subsidiaries, Zhengzhou Zhengdie Valve Co, Ltd., Henan Kaifeng High Pressure Valve Co., Ltd., Tai Zhou Tai De Valve Co., Ltd. and Yangzhou Rock Valve Lock Technology Co., Ltd., is engaged in development, manufacture and sale of high-quality metal valves for the electricity, petroleum, chemical, water, gas and metallurgy industries. The Company has one of the best known brand names in China’s valve industry, and its history can be traced back to 1959 when it was formed as a state-owned enterprise. The Company develops valve products by extensive research and development and owns a number of patents. It enjoys significant domestic market shares and exports to Asia and Europe. For more information, visit http://www.cvalve.com

Safe Harbor Statements

Any statements set forth above that are not historical facts are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Such factors include, but are not limited to, the Company’s ability to develop and market new products, expectations regarding the financial performance of Yangzhou Rock, the ability to acquire other companies, changes from anticipated levels of sales, changes in national or regional economic and competitive conditions, changes in relationships with customers, changes in principal product profits and other factors detailed from time to time in the Company’s filings with the United States Securities and Exchange Commission and other regulatory authorities. The Company undertakes no obligation to update or revise to the public any forward-looking statements, whether as a result of new information, future events or otherwise. This press release was developed by China Valves, and is intended solely for informational purposes and is not to be construed as an offer or solicitation of an offer to buy or sell the Company’s stock. This press release is based upon information available to the public, as well as other information from sources which management believes to be reliable, but it is not guaranteed by China Valves to be accurate, nor does China Valves purport it to be complete. Opinions expressed herein are those of management as of the date of publication and are subject to change without notice.

Popularity: 1% [?]

Lihua International, Inc., (Nasdaq: LIWA), a leading Chinese developer, designer, manufacturer, marketer and distributor of low cost, high quality alternatives to pure copper superfine and magnet wire, today announced new production capacity expansion following the recent completion of the Company’s initial public offering of common stock.

The Company has begun production on four new proprietary high speed manufacturing lines. The new lines increase Lihua’s copper wire capacity from 1,000 metric tons per month to 1,500 metric tons per month and CCA wire capacity from 500 metric tons per month to 600 metric tons per month.

To supplement and capitalize on its well-established CCA business and proprietary cleaning technologies, at the end of the first quarter of 2009, Lihua began utilizing refined, or recycled, copper to manufacture and sell low content oxygen copper cable and copper magnet wire to its existing customer base. Lihua’s copper recycling facility operates two horizontal smelters for a current production capacity of 25,000 tons per annum.

“As CCA and recycled copper magnet wire are increasingly accepted as alternatives to pure copper wire magnet wire, we are leveraging our fine wire expertise to develop new products and processes while aggressively growing our production capacity to meet surging domestic demand,” said Jianhua Zhu, Chairman and Chief Executive Officer of Lihua. “Our highly scalable production facilities and competitive supply chain advantages allow us to steadily add capacity while maintaining healthy margins. We believe that our emphasis on technological innovation and production efficiency has contributed significantly to our leading industry position in China and will enable us to capture a growing share of an enormous market opportunity.”

Market Demand

Lihua’s proprietary copper-cleaning technology, which produces 99.96% copper purity, puts the Company in a leadership position within the world’s largest addressable market for copper consumption. China ranks as the largest copper consuming country in the world with a market share of approximately 22% of global demand. Experts have indicated that China’s four trillion RMB stimulus package should assist in sustaining the rate of copper demand through ongoing and accelerating housing and infrastructure investments.

About Lihua International, Inc.

Lihua International, through its two wholly-owned subsidiaries, Lihua Electron and Lihua Copper, is a leading value-added manufacturer of copper replacement products for China’s rapidly growing magnet and fine wire market. Lihua is one of the first vertically integrated companies in China to develop, design, manufacture, market and distribute lower cost, high quality, alternatives to pure copper magnet wire. Lihua’s products include copper-clad aluminum wire (”CCA”) and recycled scrap copper wire and are sold in China either directly to manufacturers or through distributors in the wire and cable industries and manufacturers in the consumer electronics, white goods, automotive, utility, telecommunications and specialty cable industries. Lihua’s corporate and manufacturing headquarters are located in the heart of China’s copper industry in Danyang, Jiangsu Province. http://www.lihuaintl.com

As of Monday, October 5, 2009, Lihua was ranked the No. 1 performing IPO to date in 2009 with a 152% increase in stock price since the beginning of trading on September 4th.

To be added to the Company’s email distribution for future news releases, please send your request to lihua@tpg-ir.com.

Popularity: 4% [?]

China Security & Surveillance Technology, Inc. (CSR), a leading provider of digital surveillance technology in the PRC, today announced that it has completed its registered direct offering with certain accredited investors for 9.36 million shares of its common stock at a price at $6.25 per share under its Form S-3 Registration Statement resulting in gross proceeds to the Company of $58.5 million, before deducting placement agent fees and expenses of the offering. In addition, the Company has issued to the investors warrants to purchase 2.3 million shares of common stock, in the aggregate, at a price of $8.16 per share for a term of one year. Brean Murray, Carret & Co., LLC acted as the sole placement agent on the transaction.

The net proceeds from the offering will be used to repay the Company’s $50 million Tranche A Zero Coupon Guaranteed Senior Unsecured Convertible Notes for a purchase price of $47.5 million, as specified in a non-binding term sheet signed between the Company and Citadel Equity Fund Ltd. Pending such repayments the Company will use the remaining net proceeds from the offering for working capital and general corporate purposes.

About China Security & Surveillance Technology, Inc.

Based in Shenzhen, China, CSST manufactures, distributes, installs and services surveillance and safety products and systems as well as develops surveillance and safety related software in China. Its customers are mainly comprised of commercial and government entities and non-profit organizations. CSST has built a diversified customer base through its extensive sales and service network that includes over 150 branch offices and distribution points throughout China. To learn more about the Company visit http://www.csst.com .

Popularity: 5% [?]

China Aoxing Pharmaceutical Company, Inc. (CAXG) (”China Aoxing”), a China-based pharmaceutical company specializing in research, development, manufacturing and distribution of narcotic and pain-management products, today announced that the Company will present at the 2009 Roth China Conference on October 14, 2009. Management will meet with institutional investors throughout both October 13 and 14.

For further details, please contact your institutional sales representative.

About China Aoxing Pharmaceutical Company, Inc.

China Aoxing Pharmaceutical Company, Inc. (OTCBB: CAXG) is a pharmaceutical company located in China specializing in research, development, manufacturing and distribution of a variety of narcotics and pain-management products. It has a strategic alliance with American Oriental Bioengineering, Inc. (NYSE: AOB) to develop and market various narcotic drugs in China. Headquartered in Shijiazhuang City, the pharmaceutical capital of China, outside of Beijing, China Aoxing has China’s largest and the most advanced manufacturing facility for highly regulated narcotic medicines, addressing a very under-served and fast-growing market in China. Its facility is one of the few GMP facilities licensed for narcotics medicines. The Company is working closely with the Chinese government and SFDA to assure the strictly regulated availability to medical professionals of its narcotic drugs and pain medicines throughout China.

Statements made in this press release are forward-looking and are made pursuant to the safe harbor provisions of the Securities Litigation Reform Act of 1995. Such statements involve risks and uncertainties that may cause actual results to differ materially from those set forth in these statements. The economic, competitive, governmental, technological and other risk factors identified in the Company’s filings with the Securities and Exchange Commission, including the Form 10-KSB for the year ended June 30, 2008, may cause actual results or events to differ materially from those described in the forward looking statements in this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise.

Popularity: 4% [?]

China Security & Surveillance Technology, Inc. (CSR), a leading provider of digital surveillance technology in the PRC, today announced that it has entered into definitive agreements with certain accredited investors to sell in a registered direct offering 9.36 million shares of its common stock at a price at $6.25 per share under its Form S-3 Registration Statement resulting in gross proceeds to the Company of $58.5 million, before deducting placement agent fees and expenses of the offering. In addition, the Company has issued to the investors warrants to purchase 2.3 million shares of common stock, in the aggregate, at a price of $8.16 per share for a term of one year. The closing is subject to certain customary closing conditions and is expected to occur early next week.

The net proceeds from the offering will be used to repay the Company’s $50 million Tranche A Zero Coupon Guaranteed Senior Unsecured Convertible Notes for a purchase price of $47.5 million, as specified in a non-binding term sheet signed between the Company and Citadel Equity Fund Ltd. Pending such repayments the Company will use the net proceeds from the offering for working capital and general corporate purposes.

Mr. Guoshen Tu, Chief Executive Officer of CSST, commented, “We are very pleased by the strong interest to our offering and to be able to sign the term sheet with Citadel to retire the Tranche A Notes. We believe the combination of these two transactions will further strengthen our balance sheet, create additional cost savings, improve future cash flows, and enhance our capital structure. These ongoing efforts should augment our financial flexibility and help us support our strategic expansion and long term growth.”

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any jurisdiction. The shares of common stock may only be offered by means of a prospectus. Copies of the final prospectus supplement and accompanying base prospectus can be obtained from Brean Murray, Carret & Co., LLC (570 Lexington Avenue, 11th Floor, New York, NY 10022, fax +1-212-702- 6548), or from China Security & Surveillance Technology, Inc. (13/F, Shenzhen Special Zone Press Tower, Shennan Road, Futian District, Shenzhen, People’s Republic of China, 518034).

Existing Notes Details

On September 2, 2009, the Company restructured its two 1% Guaranteed Senior Unsecured Convertible Notes due 2012 into two new tranches of notes: the Tranche A Zero Coupon Guaranteed Senior Unsecured Convertible Notes (the “Tranche A Notes”) and the Tranche B Zero Coupon Guaranteed Senior Unsecured Notes (the “Tranche B Notes”).

The Tranche A Notes have a principal amount of $50 million, zero coupon interest, and mature on September 2, 2012. The Company will repay the principal amount in six consecutive semi-annual installments, starting March 2, 2010, with 25%, 25% and 50% of the principal amount to be repaid in the first, second and third year, respectively. The conversion price will be $10.00 per share initially, subject to customary conversion price adjustments, anti- dilution protections and a one-time price reset on March 2, 2011 (the ‘Reset Date’) based on the volume weighted average price of the Company’s shares during the 45 trading days immediately preceding the Reset Date, provided that the conversion price shall be adjusted to no lower than $6.00 per share.

The Tranche B Notes, which are not convertible, have a principal amount of $84 million, zero coupon interest, and mature on September 2, 2012. The Company will repay the principal amount in six consecutive semi-annual installments, starting March 2, 2010, with 46%, 46% and 8% of the principal amount to be repaid in the first, second and third year, respectively.

The Company is entitled to redeem the two tranches of notes at any time with no premium or penalty at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus default interest, if any.

About China Security & Surveillance Technology, Inc.

Based in Shenzhen, China, CSST manufactures, distributes, installs and services surveillance and safety products and systems as well as develops surveillance and safety related software in China. Its customers are mainly comprised of commercial and government entities and non-profit organizations. CSST has built a diversified customer base through its extensive sales and service network that includes over 150 branch offices and distribution points throughout China. To learn more about the Company visit http://www.csst.com .

Popularity: 4% [?]

China Pharma Holdings, Inc. [[CPHI.OB]], which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it has received approval to list its securities on NYSE Amex.

China Pharma expects to begin trading on NYSE Amex on Wednesday, September 30, 2009. In connection with its listing on NYSE Amex, the Company’s ticker symbol will change to “CPHI” from “CPHI.OB.”

Ms. Zhilin Li, CEO and President of China Pharma, commented, “It is a major milestone to move to NYSE Amex, and we are proud of our fulfillment of this target. We believe that NYSE Amex provides excellent exposure for companies from emerging markets, such as ours. This step underscores our commitment to generating long-term value for our shareholders.”

About China Pharma Holdings, Inc.

China Pharma Holdings, Inc. is a specialty pharmaceutical company with rapidly growing profit that develops, manufactures, and markets treatments for a wide range of high incidence and high mortality conditions in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company’s cost-effective, high margin business model is driven by market demand and supported by eight scalable GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding distribution network across 30 provinces, municipalities and autonomous regions. The Company is registered in Delaware, USA. Hainan Helpson Medical & Biotechnology Co., Ltd. (Helpson), located in Haikou City, Hainan Province, China, is a wholly owned subsidiary of China Pharma Holdings, Inc. For more information about China Pharma Holdings, Inc., please visit http://www.chinapharmaholdings.com .

Popularity: 3% [?]

GC China Turbine Corp. (GCHT) at a time of growing support for global environmental issues this week marks a milestone for the United Nations as well as for GC China Turbine Corp. Nearly 100 world leaders agreed to participate in an historic Summit on Climate Change in New York this week in order to mobilize political will and strengthen momentum for a fair, effective, and ambitious climate deal in Copenhagen this December.

The Summit marks the first UN visit for the Presidents of China and the United States. This participation clearly underlines the degree of commitment to change at the highest levels of world government. “Failure to reach broad agreement in Copenhagen would be morally inexcusable, economically short-sighted and politically unwise,” the Secretary-General said in his opening address. “Now is the moment to act in common cause.”

It is against this backdrop of political will and resultant extraordinary potential for increased industry momentum that will directly affect the future positive growth of the wind power sector in China, that GC China Turbine Corp. is pleased to announce the final framework for a definitive agreement (the “Agreement”) with Wuhan Guoce Nordic New Energy Co. Ltd., a People’s Republic of China Company (”GC Nordic”), and all related parties have met, thus paving the way for the execution of the share exchange agreement by the end of the month.

All parties have agreed to the terms and conditions of a formal, definitive agreement, which will see the Company consummate a voluntary share exchange with the parent company of GC Nordic by acquiring all of the issued and outstanding capital stock of the parent company of GC Nordic in exchange for the issuance of shares of common stock of the Company, which will represent a fifty four percent (54%) ownership interest in the Company post-Closing (the “Exchange”). As a result, upon consummation of the Exchange, the Company shall indirectly own all of the outstanding capital stock of GC Nordic. Furthermore, the previously announced $10,000,000 loan made to the Company will be converted into shares of the Company’s common stock.

It is anticipated that an announcement of the formal closing providing further details of the agreement will be made shortly.

Wuhan Guoce Nordic New Energy Co. Ltd. (GC Nordic) is a wind turbine manufacturing venture and affiliate of the highly regarded and successful multi-division Wuhan Guoce Group of Companies. The organization is a well established manufacturer of hydraulic and electronic systems offering direct access to a national client base representing a large industrial market share with extensive vertical penetration opportunities across the People’s Republic of China (”PRC”). The company holds a license to manufacture a robust and innovative wind turbine system originally developed in Europe.

Further details regarding the Company and complete details of the Exchange with GC Nordic are filed as part of the Company’s continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission’s (”SEC”) EDGAR database.

Popularity: 4% [?]

CDC Software Corporation (CDCS), a global provider of enterprise software applications and services, today announced, at a press conference in Shanghai, that it has executed a term sheet to acquire up to a 51 percent stake, in three tranches prior to March 31, 2012, in Beijing-based Hejia Software Technology Co. Ltd, a major ERP software provider in China.

The acquisition of this interest in Hejia Software is subject to several customary closing conditions, including the execution of definitive documentation related to the deal, the receipt of all requisite approvals and consents, and the satisfactory completion of due diligence by CDC Software.

Founded in 1998, Hejia Software Technology is a major ERP vendor in the China enterprise market, and currently has offices in Shanghai, Guangzhou, Changzhou, and other places throughout the China region. The company’s main product, HJSOFT, is a web-based solution featuring functionality in supply chain management, ERP, quality assurance, financial management, and customer relationship management. Hejia Software’s products are used by more than 400 customers in industries that include Industrial, Food and Beverage, Healthcare, Publishing and Chemical. Some of Hejia Software’s customers include Changlin Company Limited, Shandong Dong-e E-Jiao Group, Zizhu Pharmaceutical, Coca-Cola, Bosch Rexroth, Novo Nordisk, and Hörmann.

In the event the acquisition is completed, Hejia Software Technology will be the latest addition to CDC Software’s successful Franchise Partner Program and the second franchise partner in China following last year’s previously announced acquisition of a majority stake in Integrated Solutions Ltd. (ISL), a provider of ERP solutions for small and medium-sized discrete manufacturers. Formed in 2006, CDC Software’s Franchise Partner Program helps CDC Software establish strategic relationships with partners in selected geographies, with a focus on emerging markets, through majority control, as well as minority investments. CDC Software currently has seven other franchise partners located in India, China, South America, Spain and Mexico.

The acquisition of Hejia Software Technology is part of CDC Software’s strategic plans to expand its geographic footprint and increase sales by accessing rapidly growing economies. As part of that strategy, CDC Software expects to continue to pursue other strategic investments in China.

If the transaction is completed, Hejia Software is expected to resell CDC Software’s Ross ERP, CDC Supply Chain and CDC Platinum HRM through an OEM partnership in mainland China, and Hejia is also expected to leverage CDC Software’s extensive global infrastructure to expand sales of its own products.

“We are very pleased to invest in Hejia Software, a major ERP software provider in China that fits into our expansion strategy in that country,” said Peter Yip, CEO of CDC Software. “We believe China holds significant growth opportunity for the enterprise software market and that this investment will help us to increase our market penetration in this country. Hejia is also expected to help us accelerate our organic growth rate as Hejia will help sell CDC Software solutions into the China market. Together with other potential investments and partnerships, we hope to see sales in China making up a more significant portion of our revenue in the near future.”

“We are excited about CDC Software’s investment in Hejia Software,” Chen Jia, chairman and CEO of Hejia Software. “CDC Software’s Franchise Partner Program investments and acquisitions have performed well under support from CDC Software’s global infrastructure. Together, we hope to not only help build Hejia Software’s market share, but also further expand CDC Software’s products into this potentially lucrative market.”

This pending acquisition also represents a continuation of CDC Software’s restarted investment program following the completion of its initial public offering on August 6, 2009. Earlier this month, CDC Software completed its previously announced acquisition of Categoric, a supply chain event management software provider.

Popularity: 3% [?]

China Natural Gas, Inc. (CHNG), a leading provider of compressed natural gas (CNG) for vehicular fuel and pipeline natural gas for industrial, commercial and residential use in Xi’an, China, today announced that it closed the sale of an additional 858,750 shares of common stock at the public offering price of $8.75 per share, pursuant to the over-allotment option exercised in full by the underwriter in connection with its public offering that closed on September 9, 2009.

The exercise of the over-allotment option brings the total number of shares sold by China Natural Guess in this public offering to 6,583,750. The aggregate net proceeds received by the Company totaled approximately $54.7 million, after deducting underwriting discounts and commissions and the Company’s roadshow travel expenses but before other expenses.

Roth Capital Partners, LLC acted as the sole book runner for the offering, and Simmons & Company International acted as a co-manager for the offering.

The net proceeds from the offering will be used for the construction of the Company’s liquefied natural gas (LNG) facility, the acquisition of eight CNG fueling stations, the purchase of eight CNG trucks to transport CNG and the establishment of a joint venture company with China National Petroleum Corporation Kunlun Natural Gas Co., Ltd., as well as for general working capital purposes.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction. Copies of the prospectus supplement relating to this offering may be obtained from Roth Capital Partners, LLC, Attention: Equity Capital Markets, 24 Corporate Plaza Drive, Newport Beach, CA 92660, by telephone at (949) 720-7194, or via email at rothecm@roth.com .

About China Natural Gas, Inc.

China Natural Gas transports and sells natural gas to vehicular fueling terminals, as well as commercial, industrial and residential customers through its distribution networks in China’s Shaanxi and Henan Provinces. The Company owns approximately 120 km of high pressure pipelines and operates 23 CNG fuelling stations in Shaanxi Province and 12 CNG fuelling stations in Henan Province. China Natural Gas’ four primary business lines include: (1) the distribution and sale of CNG through Company-owned CNG fuelling stations for hybrid (natural gas/gasoline) powered vehicles; (2) the installation, distribution and sale of piped natural gas to residential, commercial and industrial customers through Company-owned pipelines; (3) the distribution and sale of gasoline through Company-owned CNG fuelling stations for hybrid (natural gas/gasoline) powered vehicles; and (4) the conversion of gasoline — fueled vehicles to hybrid (natural gas/gasoline) powered vehicles through its auto conversion division.

Popularity: 5% [?]

China Gengsheng Minerals, Inc. [[CHGS.OB]], a materials technology company in China with products capable of withstanding high temperature, saving energy and boosting productivity in certain industries such as steel and oil, today announced that it has received $337,000 (RMB 2.3 million) from the Henan Provincial Government in subsidy for the development and commercialization of Gengsheng’s new product line, the fine precision abrasives (”the abrasives”).

The abrasives are ultra-fine grains of silicon carbide, white fused alumina, and blend materials used in the cutting and polishing of optical equipment, semiconductors, and fine metal surfaces to improve finish quality. Gengsheng uses its patented technology to focus on producing lapping abrasives and polishing compounds for the processing of silicon wafers among Chinese solar cell manufacturers, who at the moment import such abrasive products from Japan and France. To compete successfully with import materials, Gengsheng will secure sources of raw materials in Xinjiang Uygur Autonomous Region to achieve low-cost advantage, along with its own proprietary technology to improve manufacturing efficiency.

Gengsheng’s abrasive production facilities, which are located in Gongyi City, Henan Province, have an annual capacity of 20,000 tons.

“Our solar industry-targeted abrasives have now been officially recognized as a high and new technology industrial product by the Henan Provincial Government and will continue to receive government support including further subsidies and low-interest loans,” said Mr. Shunqing Zhang, Chairman and CEO of Gengsheng. “With crude oil prices climbing back from depressed levels and the Chinese government’s strong solar stimulus, awarding about 10GW of PV projects worth more than $20 billion in July and August of this year alone, we are confident that the market for our ingot-slicing and panel-polishing abrasives is poised for robust growth in the near future, with our government mandating 10GW of installed solar power by the year 2020, from under 100MW of total installed solar power capacity at the end of 2008.”

Gengsheng last year signed its first sales contract for the abrasives with a Taiwan-based customer. The term of the contract is five years, with 300-500 tons of the product delivered each month. The value of the contract was not disclosed.

About China Gengsheng Minerals, Inc.

China Gengsheng Minerals, Inc. (”Gengsheng”) develops, manufactures and markets a broad range of high-tech industrial material products, including monolithic refractories, industrial ceramics and fracture proppants. A market leader offering customized solutions, Gengsheng sells its products primarily to the iron-and-steel industry as heat-resistant components for steel-making furnaces, industrial kilns and other high-temperature vessels to guarantee and improve the productivity of those expensive pieces of equipment while reducing their consumption of energy. Founded in 1986 and based in China’s Henan province, Gengsheng currently has over 200 customers in the iron, steel, oil, glass, cement, aluminum and chemical businesses located in China and in 11 other countries. Gengsheng conducts business through Gengsheng International Corporation, a British Virgin Islands company, and its Chinese subsidiaries, which are Henan Gengsheng Refractories Co., Ltd., Zhengzhou Duesail Fracture Proppant Co., Ltd. and Henan Gengsheng High Temperature Materials Co., Ltd.

For more information about the Company, please visit http://www.gengsheng.com.

Popularity: 3% [?]